bioRxiv Science⌕ Search

Biology subjects

Uga, H.

Publications and source records attributed to Uga, H..

2 recordsLinked to original sources

Pathway-Centric Integration of CRISPR Fitness with Molecular Features Draws Cancer State Maps

Cancer cells display heterogeneous pathway activity that shapes therapeutic vulnerability, but mapping it remains challenging. Transcriptomic scores do not directly measure functional activity, and CRISPR knockout data alone lack molecular interpretability. We introduce StateMap, a pathway-centric framework integrating gene expression and genome-wide CRISPR knockout fitness data from the Cancer Dependency Map. For a given pathway, StateMap selects features by co-dependency and mutual information, then projects cell lines into a low-dimensional space reflecting pathway activity and molecular state. Applied to the Hippo pathway, it resolved five functional states refining the YAP-on/YAP-off dichotomy. Notably, the Hippo-strong state showed selective dependence on integrin V{beta}5; ITGAV depletion triggered Hippo-dependent cell aggregation and G1 arrest via enhanced cell-cell adhesion. Machine learning transfer to TCGA identified a matching subtype with poor prognosis, nominated NNMT as a biomarker, and predicted sensitivity to the V inhibitor Cilengitide. StateMap enables pathway-specific state mapping and discovery of state-selective therapeutic vulnerabilities.

cancer biology↗

Targeting dermatophyte Cdc42 and Rac GTPase signaling to hinder hyphal elongation and virulence

The identification of novel molecular targets for antifungal drugs is critical due to limited treatment options and drug-resistance threats. We screened inhibitors of small GTPases, molecular switches in signal transduction, in Trichophyton rubrum, the primary cause of dermatophytosis. Our study found that chemical and genetic inhibition of Cdc42 and Rac GTPases, which are involved in cellular morphological changes, significantly impair hyphal formation, and are crucial for pathogenic fungal growth and virulence. Genetic repression of Cdc24, a guanine nucleotide exchange factor of Cdc42 and Rac, led to hyphal growth defects, abnormal cell morphology, and cell death. Chemical screening identified EHop-016 as an inhibitor of Cdc24 activity, which improved outcomes in in vitro nail infection and invertible infection models of T. rubrum. Our results suggest the Cdc24-Cdc42/Rac pathway as a promising therapeutic target for antifungal agent development, with EHop-016 as a potential lead compound.

microbiology↗